New drug that could treat aggressive forms of cancer created at U of A
Andrea Dion - 20 January 2021
EDMONTON -- The University of Alberta is touting a new drug that could treat breast and blood cancers.
The new drug, PCLX-001, is set to begin human trials later this year, in three Canadian centres, including the Cross Cancer Institute in Edmonton.
“It’s another exciting stepping stone to finding out if this is going to be a new cancer treatment,” John Mackey, professor and director of oncology trials in the Faculty of Medicine & Dentistry, said.